Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,340,961
-$233,690 QoQ
Shares Held
303,639
-5.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. GMAB ranks #34 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,340,961 | 303,639 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,574,651 | 319,592 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,051,880 | 34,152 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $233,858 | 7,625 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $201,743 | 9,765 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $185,538 | 9,476 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,908,525 | 283,111 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $17,075,849 | 700,404 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $18,181,679 | 723,505 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $22,327,125 | 746,477 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $17,739,080 | 557,132 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $20,787,889 | 589,393 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,188,839 | 636,381 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $24,666,983 | 653,257 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $26,946,389 | 635,828 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $21,576,772 | 671,546 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,917,851 | 674,603 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,637,484 | 598,051 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,934,480 | 503,905 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,257,108 | 509,316 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,033,450 | 515,147 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $21,746,361 | 662,393 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $29,862,817 | 734,452 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $25,205,947 | 688,499 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $22,177,987 | 654,411 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $19,932,372 | 940,650 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||